Fundraising Fox
Cambridge Capital Group
Angel networkCambridge · Pre-Seed–Growth · 2 people tracked
Find your way into Cambridge Capital Group
11,022 people in our graph share verified history with the Cambridge Capital Group team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Cambridge Capital Group is an angel network of 80+ private investors, family offices, and venture funds focused on early-stage technology companies in the UK's Golden Triangle around Cambridge, London, and Oxford. Members co-invest individually or via syndicate in seed, start-up, and early-growth opportunities, with check sizes ranging from around £10k from a single member up to £1m-£2m from a syndicate. The group backs sectors where Cambridge is strong, including engineering, materials, medtech, biotech, AI/ML/robotics, and B2B digital services, alongside newer areas such as legaltech, cybersecurity, logistics, spacetech, and agritech. Its portfolio has produced multiple profitable exits via AIM listings and trade sales.
Source: firm website, verified Sep 26, 2026.
Team · 2 people
from curated
What they invest in
from 8 of 13 portfolio companiesAI & Machine Learning ×3Biotech ×3Healthtech ×3Medical Devices ×3SaaS ×3Deep Tech ×2Enterprise Software ×2Fintech ×2
HQs:United Kingdom×3
Investments · 13 tracked
founders shown can be your intro pathBy year:2026 · 12006 · 12 dated
iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.
BiotechHealthtechMedical DevicesWhiteley, GB
Co-investorsMeridian Health VenturesInnovate UKRaw VenturesFuture Planet CapitalUK Innovation & Science Seed Fund
Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.
BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB
Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in
Co-investorsThe FSE GroupFound CapitalStart CodonEMV CapitalMartlet CapitalParkwalk Advisors
Solytics Partners provides risk management, financial crime and compliance (AML/CFT), data analytics, and ESG/climate risk services and technology to financial institutions such as banks, capital markets firms, and insurers.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS
Co-investorsMartlet CapitalQED Investors
AreCor develops proprietary pharmaceutical products for diabetes, obesity, and cardiometabolic diseases using its Arestat technology platform.
BiotechDeep TechHealthtech
Sarah Howellin
Co-investorsAlbionVCCalculus Capital Ltd.Seneca Partners
Enval develops a microwave-induced pyrolysis technology that recycles low-density and complex plastic packaging waste, converting it into oil feedstock to produce new plastic.
Circular EconomyCleantechNew Materials
Co-investorsAnglia Capital GroupCambridge Angels groupGEIF Ventures
Featurespace provides an AI-powered fraud detection platform deployed across financial institutions, payment processors, and insurance companies globally.
AI & Machine LearningCybersecurityFintech
Co-investorsBright Pixel CapitalHighland EuropeInsight PartnersMissionOGTTV Capital
IQGeo builds AI-powered geospatial network management software that unifies the planning, design, construction, and operation of physical network infrastructure into a single platform.
AI & Machine LearningEnterprise SoftwareSaaS
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings.
Digital HealthHealthtechMedical DevicesCambridge, GB
Bart A. Lewin(Chief Executive Officer)in
Co-investorsCambridge Angels group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
10to8Cambridge CMOS SensorsOval Medical TechnologiesTouchtype LimitedUbisense
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Cambridge Capital Group made?
- Cambridge Capital Group has 13 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Cambridge Capital Group invest at?
- Cambridge Capital Group invests at the Pre-Seed, Seed, Series A, Growth stages.
- What is Cambridge Capital Group's typical check size?
- Cambridge Capital Group typically writes checks of $10K – $2M.
- What sectors does Cambridge Capital Group focus on?
- Cambridge Capital Group focuses on AgTech, AI & Machine Learning, Biotech, Cybersecurity, Deep Tech, Enterprise Software, Fintech, Hardware, IoT, LegalTech, Logistics & Supply Chain, Medical Devices, New Materials, Robotics, SaaS, Space Tech.
- Where is Cambridge Capital Group located?
- Cambridge Capital Group is headquartered in Cambridge, GB.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
MPG Fund is an early-stage venture investor backing technology startups.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Alpha Edison is an early-stage venture firm that partners with entrepreneurs using technology to unlock latent demand in markets where consumer and business behaviors are shifting.